Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD73: A Promising Biomarker in Cancer Patients.
Turiello R, Pinto A, Morello S. Turiello R, et al. Front Pharmacol. 2020 Nov 16;11:609931. doi: 10.3389/fphar.2020.609931. eCollection 2020. Front Pharmacol. 2020. PMID: 33364969 Free PMC article. No abstract available.
Thrombo-Inflammation: A Focus on NTPDase1/CD39.
Morello S, Caiazzo E, Turiello R, Cicala C. Morello S, et al. Among authors: turiello r. Cells. 2021 Aug 27;10(9):2223. doi: 10.3390/cells10092223. Cells. 2021. PMID: 34571872 Free PMC article. Review.
Enzyme activity of circulating CD73 in human serum.
Morello S, Turiello R, Madonna G, Pinto A, Ascierto PA, Capone M. Morello S, et al. Among authors: turiello r. Methods Enzymol. 2019;629:257-267. doi: 10.1016/bs.mie.2019.05.044. Epub 2019 Jun 17. Methods Enzymol. 2019. PMID: 31727244
A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice.
De Marchi E, Pegoraro A, Turiello R, Di Virgilio F, Morello S, Adinolfi E. De Marchi E, et al. Among authors: turiello r. Front Cell Dev Biol. 2022 May 18;10:876510. doi: 10.3389/fcell.2022.876510. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35663396 Free PMC article.
Adenosine Signaling in the Tumor Microenvironment.
Antonioli L, Fornai M, Pellegrini C, D'Antongiovanni V, Turiello R, Morello S, Haskó G, Blandizzi C. Antonioli L, et al. Among authors: turiello r. Adv Exp Med Biol. 2021;1270:145-167. doi: 10.1007/978-3-030-47189-7_9. Adv Exp Med Biol. 2021. PMID: 33123998
Frequency of circulating CD8+CD73+T cells is associated with survival in nivolumab-treated melanoma patients.
Capone M, Fratangelo F, Giannarelli D, Sorrentino C, Turiello R, Zanotta S, Galati D, Madonna G, Tuffanelli M, Scarpato L, Grimaldi AM, Esposito A, Azzaro R, Pinto A, Cavalcanti E, Pinto A, Morello S, Ascierto PA. Capone M, et al. Among authors: turiello r. J Transl Med. 2020 Mar 11;18(1):121. doi: 10.1186/s12967-020-02285-0. J Transl Med. 2020. PMID: 32160899 Free PMC article.
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Turiello R, Capone M, Giannarelli D, Morretta E, Monti MC, Madonna G, Mallardo D, Festino L, Azzaro R, Levesque MP, Imhof L, Weide B, Amaral T, Chevrier M, Sucker A, Rutkowski P, Schadendorf D, Lebbe C, Luke JJ, Wistuba-Hamprecht K, Dummer R, Pinto A, Morello S, Ascierto PA. Turiello R, et al. J Immunother Cancer. 2020 Dec;8(2):e001689. doi: 10.1136/jitc-2020-001689. J Immunother Cancer. 2020. PMID: 33361405 Free PMC article.
20 results